Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Hyal's treatment for sun spots approved in the U.K.

July 3, 1997

Celtrix's SomatoKine enters phase II feasibility study for the treatment of burns

July 2, 1997

Cellegy's antiwrinkling product enters clinical trials

July 1, 1997

Preclinical results with Anika's INCERT promising

July 1, 1997

Antipruritogenic effect of Kochia Fructus extract and active components

June 26, 1997

Agents for psoriasis and cancers from Roche

June 20, 1997

RXR-selective compounds disclosed by Allergan

June 20, 1997

General Hospital Corp. and Shiseido disclose psoriastatin polypeptides

June 18, 1997

Tazorac approved in the U.S.

June 18, 1997

La Jolla Cancer Res. Found. discloses integrin-binding peptides

June 17, 1997

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...